Vaikom Mahadevan to Risk Factors
This is a "connection" page, showing publications Vaikom Mahadevan has written about Risk Factors.
Connection Strength
0.228
-
Caughron H, Parikh D, Allison Z, Deuse T, Mahadevan VS. Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease. Catheter Cardiovasc Interv. 2021 07 01; 98(1):159-167.
Score: 0.082
-
Hainstock MR, Fleming G, Kim D, Aboulhosn J, Levi D, Krasuski R, Sommer R, Torres AJ, Gray R, Kereiakes D, Leventhal A, Gillespie M, Szeto W, Zajarias A, Shahanavaz S, Steinberg ZL, Jones TK, Mahadevan VS, Moore P, Elmariah S, Shirali G, Li W, Babaliaros V, Lim DS. Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial. Circ Cardiovasc Interv. 2026 May; 19(5):e016361.
Score: 0.029
-
Torres AJ, Dimas VV, Shahanavaz S, Balzer D, Morgan G, Lim DS, Armstrong AK, Berman D, Babaliaros V, Kim D, Gillespie MJ, Sommer R, Aboulhosn J, Jones TK, Mahadevan VS, Stapleton G, Ma Y, Shirali G, Parthiban A, Blanke P, Leipsic J, Zahn E. Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials. Circ Cardiovasc Interv. 2026 Apr; 19(4):e015873.
Score: 0.029
-
Krishna MM, Joseph M, Ezenna C, Pereira V, Rossi R, Akman Z, Rubens M, Mahadevan VS, Nanna MG, Goldsweig AM. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis. Cardiovasc Revasc Med. 2025 10; 79:78-89.
Score: 0.028
-
Dimas VV, Babaliaros V, Kim D, Lim DS, Morgan G, Jones TK, Armstrong AK, Berman D, Aboulhosn J, Mahadevan VS, Gillespie MJ, Balzer D, Zellers T, Yu X, Shirali G, Parthiban A, Leipsic J, Blanke P, Zahn E, Shahanavaz S. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2287-2297.
Score: 0.026
-
Agarwal A, Thombley R, Broberg CS, Harris IS, Foster E, Mahadevan VS, John A, Vittinghoff E, Marcus GM, Dudley RA. Age- and Lesion-Related Comorbidity Burden Among US Adults With Congenital Heart Disease: A Population-Based Study. J Am Heart Assoc. 2019 10 15; 8(20):e013450.
Score: 0.019
-
Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O'Hair D, Dumonteil N, Rod?s-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa AA, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O'Neill W. Transcatheter Mitral Valve Replacement in?Native?Mitral Valve Disease With Severe?Mitral?Annular Calcification: Results From the First Multicenter Global Registry. JACC Cardiovasc Interv. 2016 07 11; 9(13):1361-71.
Score: 0.015